07.01.2013 Views

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

acromegaly or gigantism in individuals with appropriate symptoms or signs. In successfully treated<br />

patients, both levels should be within the normal range, ideally within the lower third. In both diagnosis<br />

and follow-up, IGF-1 levels correlate better with clinical disease activity than IGFBP-3 levels. Increased<br />

concentrations of IGF-1 are normal during pregnancy however reference ranges on this population have<br />

not been formally established in our institution. After transsphenoidal removal of pituitary tumors in<br />

patients with acromegaly, IGF-I concentration starts to decrease and returns to normal levels in most<br />

patients postoperatively by the fourth day.(1) Persons with anorexia or malnutrition have low values of<br />

IGF-1. IGF-1 is a more sensitive indicator than prealbumin, retinol-binding protein, or transferrin for<br />

monitoring nutritional repletion. Puberty onset, ie the transition from Tanner stage 1 (prepubertal) to<br />

Tanner stage 2 (early pubertal), occurs for girls at a median age of 10.5 (+/- 2) years and for boys at a<br />

median age of 11.5 (+/-2) years. There is evidence that it may occur up to 1 year earlier in obese girls and<br />

in African-American girls. <strong>By</strong> contrast, for boys there is no definite proven relationship between puberty<br />

onset and body weight or ethnic origin. Progression through Tanner stages is variable. Tanner stage 5<br />

(young adult) should be reached by age 18. IGF-1 reference values according to Tanner stages I–V(2)<br />

-Males - Stage I: 63-279 ng/mL - Stage II: 75-420 ng/mL - Stage III: 94-765 ng/mL - Stage IV: 192-861<br />

ng/mL - Stage V: 171-814 ng/mL -Females - Stage I: 49-342 ng/mL - Stage II: 115-428 ng/mL - Stage<br />

III: 145-760 ng/mL - Stage IV: 244-787 ng/mL - Stage V: 143-859 ng/mL<br />

Reference Values:<br />

Age ng/mL 0.1 Percentile (ng/mL)<br />

15 days-5 months 48-313 39<br />

6-11 months 57-344 34<br />

1 year 55-327 33<br />

2 years 51-303 31<br />

3 years 49-289 30<br />

4 years 49-283 29<br />

5 years 50-286 30<br />

6 years 52-297 31<br />

7 years 52-300 31<br />

8 years 58-329 35<br />

9 years 67-373 41<br />

10 years 80-438 49<br />

11 years 101-538 62<br />

12 years 131-690 82<br />

13 years 172-872 108<br />

14 years 215-1,026 137<br />

15 years 236-1,060 153<br />

16 years 227-964 150<br />

17 years 199-795 133<br />

18 years 170-640<br />

19 years 147-527<br />

20 years 132-457<br />

21-25 years 116-341<br />

26-30 years 117-321<br />

31-35 years 113-297<br />

Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong>Laboratories.com Page 1041

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!